BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 25569433)

  • 1. Assessment of incidental findings in 232 whole-exome sequences from the Baylor-Hopkins Center for Mendelian Genomics.
    Jurgens J; Ling H; Hetrick K; Pugh E; Schiettecatte F; Doheny K; Hamosh A; Avramopoulos D; Valle D; Sobreira N
    Genet Med; 2015 Oct; 17(10):782-8. PubMed ID: 25569433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular findings among patients referred for clinical whole-exome sequencing.
    Yang Y; Muzny DM; Xia F; Niu Z; Person R; Ding Y; Ward P; Braxton A; Wang M; Buhay C; Veeraraghavan N; Hawes A; Chiang T; Leduc M; Beuten J; Zhang J; He W; Scull J; Willis A; Landsverk M; Craigen WJ; Bekheirnia MR; Stray-Pedersen A; Liu P; Wen S; Alcaraz W; Cui H; Walkiewicz M; Reid J; Bainbridge M; Patel A; Boerwinkle E; Beaudet AL; Lupski JR; Plon SE; Gibbs RA; Eng CM
    JAMA; 2014 Nov; 312(18):1870-9. PubMed ID: 25326635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Next-generation sequencing using a pre-designed gene panel for the molecular diagnosis of congenital disorders in pediatric patients.
    Lim EC; Brett M; Lai AH; Lee SP; Tan ES; Jamuar SS; Ng IS; Tan EC
    Hum Genomics; 2015 Dec; 9():33. PubMed ID: 26666243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The implications of familial incidental findings from exome sequencing: the NIH Undiagnosed Diseases Program experience.
    Lawrence L; Sincan M; Markello T; Adams DR; Gill F; Godfrey R; Golas G; Groden C; Landis D; Nehrebecky M; Park G; Soldatos A; Tifft C; Toro C; Wahl C; Wolfe L; Gahl WA; Boerkoel CF
    Genet Med; 2014 Oct; 16(10):741-50. PubMed ID: 24784157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A community-based resource for automatic exome variant-calling and annotation in Mendelian disorders.
    Mutarelli M; Marwah V; Rispoli R; Carrella D; Dharmalingam G; Oliva G; di Bernardo D
    BMC Genomics; 2014; 15 Suppl 3(Suppl 3):S5. PubMed ID: 25078076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exome sequencing covers >98% of mutations identified on targeted next generation sequencing panels.
    LaDuca H; Farwell KD; Vuong H; Lu HM; Mu W; Shahmirzadi L; Tang S; Chen J; Bhide S; Chao EC
    PLoS One; 2017; 12(2):e0170843. PubMed ID: 28152038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency and management of medically actionable incidental findings from genome and exome sequencing data: a systematic review.
    Elfatih A; Mohammed I; Abdelrahman D; Mifsud B
    Physiol Genomics; 2021 Sep; 53(9):373-384. PubMed ID: 34250816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and Validation of Clinical Whole-Exome and Whole-Genome Sequencing for Detection of Germline Variants in Inherited Disease.
    Hegde M; Santani A; Mao R; Ferreira-Gonzalez A; Weck KE; Voelkerding KV
    Arch Pathol Lab Med; 2017 Jun; 141(6):798-805. PubMed ID: 28362156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Centers for Mendelian Genomics: a new large-scale initiative to identify the genes underlying rare Mendelian conditions.
    Bamshad MJ; Shendure JA; Valle D; Hamosh A; Lupski JR; Gibbs RA; Boerwinkle E; Lifton RP; Gerstein M; Gunel M; Mane S; Nickerson DA;
    Am J Med Genet A; 2012 Jul; 158A(7):1523-5. PubMed ID: 22628075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of ACMG-Guideline-Based Variant Classification of Cancer Susceptibility and Non-Cancer-Associated Genes in Families Affected by Breast Cancer.
    Maxwell KN; Hart SN; Vijai J; Schrader KA; Slavin TP; Thomas T; Wubbenhorst B; Ravichandran V; Moore RM; Hu C; Guidugli L; Wenz B; Domchek SM; Robson ME; Szabo C; Neuhausen SL; Weitzel JN; Offit K; Couch FJ; Nathanson KL
    Am J Hum Genet; 2016 May; 98(5):801-817. PubMed ID: 27153395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of pathogenic variants from the ClinVar database in healthy people using next-generation sequencing.
    Rančelis T; Arasimavičius J; Ambrozaitytė L; Kavaliauskienė I; Domarkienė I; Karčiauskaitė D; Kučinskienė ZA; Kučinskas V
    Genet Res (Camb); 2017 Aug; 99():e6. PubMed ID: 28851476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lessons learned from additional research analyses of unsolved clinical exome cases.
    Eldomery MK; Coban-Akdemir Z; Harel T; Rosenfeld JA; Gambin T; Stray-Pedersen A; Küry S; Mercier S; Lessel D; Denecke J; Wiszniewski W; Penney S; Liu P; Bi W; Lalani SR; Schaaf CP; Wangler MF; Bacino CA; Lewis RA; Potocki L; Graham BH; Belmont JW; Scaglia F; Orange JS; Jhangiani SN; Chiang T; Doddapaneni H; Hu J; Muzny DM; Xia F; Beaudet AL; Boerwinkle E; Eng CM; Plon SE; Sutton VR; Gibbs RA; Posey JE; Yang Y; Lupski JR
    Genome Med; 2017 Mar; 9(1):26. PubMed ID: 28327206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Actionable exomic incidental findings in 6503 participants: challenges of variant classification.
    Amendola LM; Dorschner MO; Robertson PD; Salama JS; Hart R; Shirts BH; Murray ML; Tokita MJ; Gallego CJ; Kim DS; Bennett JT; Crosslin DR; Ranchalis J; Jones KL; Rosenthal EA; Jarvik ER; Itsara A; Turner EH; Herman DS; Schleit J; Burt A; Jamal SM; Abrudan JL; Johnson AD; Conlin LK; Dulik MC; Santani A; Metterville DR; Kelly M; Foreman AK; Lee K; Taylor KD; Guo X; Crooks K; Kiedrowski LA; Raffel LJ; Gordon O; Machini K; Desnick RJ; Biesecker LG; Lubitz SA; Mulchandani S; Cooper GM; Joffe S; Richards CS; Yang Y; Rotter JI; Rich SS; O'Donnell CJ; Berg JS; Spinner NB; Evans JP; Fullerton SM; Leppig KA; Bennett RL; Bird T; Sybert VP; Grady WM; Tabor HK; Kim JH; Bamshad MJ; Wilfond B; Motulsky AG; Scott CR; Pritchard CC; Walsh TD; Burke W; Raskind WH; Byers P; Hisama FM; Rehm H; Nickerson DA; Jarvik GP
    Genome Res; 2015 Mar; 25(3):305-15. PubMed ID: 25637381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency and spectrum of actionable pathogenic secondary findings in 196 Korean exomes.
    Jang MA; Lee SH; Kim N; Ki CS
    Genet Med; 2015 Dec; 17(12):1007-11. PubMed ID: 25856671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The burden of pathogenic variants in clinically actionable genes in a founder population.
    Lynch MT; Maloney KA; Pollin TI; Streeten EA; Xu H; ; Shuldiner AR; Van Hout CV; Gonzaga-Jauregui C; Mitchell BD
    Am J Med Genet A; 2021 Nov; 185(11):3476-3484. PubMed ID: 34467620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Findings of a 1303 Korean whole-exome sequencing study.
    Kwak SH; Chae J; Choi S; Kim MJ; Choi M; Chae JH; Cho EH; Hwang TJ; Jang SS; Kim JI; Park KS; Bang YJ
    Exp Mol Med; 2017 Jul; 49(7):e356. PubMed ID: 28706299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germline Mutations for Novel Candidate Predisposition Genes in Sporadic Schwannomatosis.
    Min BJ; Kang YK; Chung YG; Seo ME; Chang KB; Joo MW
    Clin Orthop Relat Res; 2020 Nov; 478(11):2442-2450. PubMed ID: 32281771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical implications of technical accuracy in genome sequencing.
    Goldfeder RL; Priest JR; Zook JM; Grove ME; Waggott D; Wheeler MT; Salit M; Ashley EA
    Genome Med; 2016 Mar; 8(1):24. PubMed ID: 26932475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective Evaluation of the Utility of Whole Exome Sequencing in Dilated Cardiomyopathy.
    Ramchand J; Wallis M; Macciocca I; Lynch E; Farouque O; Martyn M; Phelan D; Chong B; Lockwood S; Weintraub R; Thompson T; Trainer A; Zentner D; Vohra J; Chetrit M; Hare DL; James P
    J Am Heart Assoc; 2020 Jan; 9(2):e013346. PubMed ID: 31931689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical application of whole-exome sequencing across clinical indications.
    Retterer K; Juusola J; Cho MT; Vitazka P; Millan F; Gibellini F; Vertino-Bell A; Smaoui N; Neidich J; Monaghan KG; McKnight D; Bai R; Suchy S; Friedman B; Tahiliani J; Pineda-Alvarez D; Richard G; Brandt T; Haverfield E; Chung WK; Bale S
    Genet Med; 2016 Jul; 18(7):696-704. PubMed ID: 26633542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.